The sale is pre-planned under a 10b5-1 arrangement, reducing immediate negative signal; however, traders should monitor for follow-through sales and assess whether additional insider selling follows, which could indicate broader sentiment.
Price Chart
Executive Summary
Joana Goncalves, an officer of Oruka Therapeutics, filed a Form 144 to notify intent to sell up to 21,000 shares of common stock received from exercised stock options. The sale is part of a pre-arranged 10b5-1 plan and follows prior sales in February and March 2026.
Key Facts
- Joana Goncalves, an officer at Oruka Therapeutics, filed Form 144 for the proposed sale of 21,000 shares.
- The shares were acquired through the exercise of stock options and are being sold under a 10b5-1 plan.
- Prior sales occurred on February 17, 2026 (7,000 shares) and March 16, 2026 (7,641 shares), totaling over 14,000 shares sold or proposed for sale recently.
- The filing date is April 15, 2026, with the underlying options exercised on that date.
Financial Impact
Approximately $1.41 million based on the reported value of $1,408,260 for 21,000 shares, or about $67.06 per share.
Risk Factors
- Perception of insider selling pressure, especially following recent transactions.
- Potential downward price pressure if the full 21,000 shares are sold rapidly.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003530 |
| Document: 0001950047-26-003530-index.html | 0001950047-26-003530 |
| Document: 0001950047-26-003530.txt | 0001950047-26-003530 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 16d ago | Insider Cluster | $93.55 $89.93 | ▼ −3.87% | ▼ −6.44% | $84.38 (−9.80%) |
Sep 1, 2026 4w ago | Insider Cluster | $91.63 $91.65 | ▼ −0.02% | ▼ −0.98% | $84.38 (+7.91%) |
Aug 28, 2026 5w ago | EFFECT | $91.15 $92.51 | ▼ −1.50% | ▼ −1.39% | $84.38 (+7.42%) |
Aug 17, 2026 6w ago | Insider Cluster | $113.08 $101.82 | ▼ −9.96% | ▼ −9.76% | $84.38 (−25.38%) |
Aug 10, 2026 7w ago | Press Release | $105.14 $112.66 | ▲ +7.15% | ▲ +7.20% | $84.38 (−19.75%) |
Aug 10, 2026 7w ago | 8-K | $105.14 $112.66 | ▲ +7.15% | ▲ +7.20% | $84.38 (−19.75%) |
Aug 9, 2026 7w ago | Institutional Cluster | $105.14 $112.66 | ▲ +7.15% | ▲ +7.20% | $84.38 (−19.75%) |
Jul 15, 2026 11w ago | Insider Cluster | $83.04 $91.95 | ▲ +10.73% | ▲ +12.40% | $84.38 (+1.61%) |
Jul 2, 2026 13w ago | Insider Cluster | $85.21 $88.27 | ▲ +3.59% | ▲ +2.66% | $84.38 (−0.97%) |
Jun 22, 2026 14w ago | Insider Cluster | $83.40 $92.49 | ▲ +10.90% | ▲ +9.89% | $84.38 (+1.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access